High Feasibility of Liquid-Based Cytological Samples for Detection of EGFR Mutations in Chinese Patients with NSCLC |
Wu, Chun-Yan
(Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine)
Hou, Li-Kun (Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine) Ren, Sheng-Xiang (Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine) Su, Bo (Laboratory, Shanghai Pulmonary Hospital Affiliated with Tongji University, Tongji University School of Medicine) Chen, Gang (Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine) |
1 | Chu H, Zhong C, Xue G, et al (2013). Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Oncol Rep, 30, 2311-5. |
2 | Alimujiang S, Zhang T, Han ZhG, et al (2013). Epidermal growth factor receptor tyrosine kinase inhibitor versus placebo as maintenance therapy for advanced nonsmall-cell lung cancer: a meta-analysis of randomized controlled trials. Asian Pac J Cancer Prev, 14, 2413-9. 과학기술학회마을 DOI ScienceOn |
3 | Aisner DL, Deshpande C, Baloch Z, et al (2013). Evaluation of EGFR mutation status in cytology specimens: an institutional experience. Diagn Cytopathol, 41, 316-23. DOI ScienceOn |
4 | Chen G, Feng J, Zhou C, et al (2013). Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutationpositive non-small-cell lung cancer (NSCLC). Ann Oncol, 24, 1615-22. DOI ScienceOn |
5 | Dejmek A, Zendehrokh N, Tomaszewska M, Edsjo A (2013). Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol, 121, 344-53. DOI ScienceOn |
6 | Ellison G, Donald E, McWalter G, et al (2010). A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples (serial online). J Exp Clin Cancer Res, 29, 132. DOI ScienceOn |
7 | Hansen T, Pedersen H, Brauner V, Hariri J (2011). Control specimens for immunocytochemistry in liquid-based cytology. Cytopathology, 22, 243-6. DOI ScienceOn |
8 | Han HS, Eom DW, Kim JH, et al (2011). EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer, 12, 380-6. DOI ScienceOn |
9 | Jing CHW, Wang ZH, Cao XH, Ma R, Wu JZh (2013) High resolution melting analysis for epidermal growth factor receptor mutations in formalin-fixed paraffin-embedded tissue and plasma free DNA from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 14, 6619-23 과학기술학회마을 DOI ScienceOn |
10 | Han JY, Park K, Kim SW, et al (2012). First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung. J Clin Oncol, 30, 1122-8. DOI ScienceOn |
11 | Inoue A, Kobayashi K, Maemondo M, et al (2013). Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemonaïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002). Ann Oncol, 24, 54-9. DOI ScienceOn |
12 | Jia XL, Chen G (2011). EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung. Lung Cancer, 74, 396-400. DOI ScienceOn |
13 | Khode R, Larsen DA, Culbreath BC, et al (2013). Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas. Cancer Cytopathol, 121, 361-9. DOI ScienceOn |
14 | Lynch TJ, Bell DW, Sordella R, et al (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med, 350, 2129-39. DOI ScienceOn |
15 | Ladanyi M, Pao W (2008). Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol, 21, 16-22. DOI ScienceOn |
16 | Malapelle U, de Rosa N, Rocco D, et al (2012). EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study. J Clin Pathol, 65, 87-91. DOI |
17 | Rich JN, Rasheed BK, Yan H (2004). EGFR mutations and sensitivity to gefitinib. N Engl J Med, 351, 1260-1. DOI ScienceOn |
18 | Pao W, Ladanyi M (2007). Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res, 13, 4954-5. DOI ScienceOn |
19 | Sun PL, Jin Y, Kim H, et al (2013). High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. Cancer Cytopathol, 121, 311-9. DOI ScienceOn |
20 | Pang B, Dettmer M, Ong CW, et al (2012). The positive impact of cytological specimens for EGFR mutation testing in nonsmall cell lung cancer: a single South East Asian laboratory's analysis of 670 cases. Cytopathology, 23, 229-36. DOI ScienceOn |
21 | Sholl LM, Xiao Y, Joshi V, et al (2010). EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry. Am J Clin Pathol, 133, 922-34. DOI ScienceOn |
22 | Wallace WA, Monaghan HM, Salter DM, Gibbons MA, Skwarski KM (2007). Endobronchial ultrasound-guided fine-needle aspiration and liquid-based thin-layer cytology. J Clin Pathol, 60, 388-91. |
23 | Wu GP, Wang EH, Li JH, Fu ZM, Han S (2009). Clinical application of the liquid-based cytological test in cytological screening of sputum for the diagnosis of lung cancer. Respirology, 14, 124-8 DOI ScienceOn |
24 | Wu YL, Zhou C, Hu CP, et al (2014). Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial. Lancet Oncol, 15, 213-22. DOI ScienceOn |
25 | Yatabe Y, Matsuo K, Mitsudomi T (2011). Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. J Clin Oncol, 29, 2972-7. DOI ScienceOn |
26 | Wang F, Fang P, Hou DY, Leng ZJ, Cao LJ (2014). Comparison of epidermal growth factor receptor mutations between primary tumors and lymph nodes in non-small cell lung cancer: a review and meta-analysis of published data. Asian Pac J Cancer Prev, 15, 4493-7. 과학기술학회마을 DOI ScienceOn |
![]() |